Back to Results
First PageMeta Content
Pharmacology / Science / Clinical research / Epidemiology / Health economics / Pharmacoeconomics / Health technology assessment / Medical technology assessment / Quality of life / Medicine / Health / Medical technology


Document Date: 2011-06-14 07:42:01

Open Document

File Size: 491,81 KB

Share Result on Facebook

City

Montreal / Rotterdam / Prague / Brussels / /

Company

iMTA Newsletter / Immunicon / Wilson / Skyline Diagnostics / Johnson & Johnson / Biotech Company / Beers Skyline Diagnostigs BV / /

Continent

Africa / /

Country

Netherlands / Kenya / France / Canada / United Kingdom / Sweden / Belgium / /

Currency

EUR / /

Facility

University of British Columbia / Ploeg Erasmus University / Roijen Erasmus University / the Netherlands Bob Löwenberg Erasmus University Medical Center / Presenters Annemieke Leunis Erasmus University / the Netherlands Chantal van Gils Erasmus University / Emory University / University of Maastricht / the Netherlands Marloes Hagemans Erasmus University Medical Center / Maastricht University / the Netherlands Lucas Goossens Erasmus University / the Netherlands Maureen Rutten-van Mölken Erasmus University / Presenters Margreet Franken Erasmus University / VU University / the Netherlands Authors Pepijn Vemer Erasmus University / the Netherlands Ken Redekop Erasmus University / Presenters Chantal van Gils Erasmus University / Hematology Ken Redekop Erasmus University / University of Oxford / the Netherlands Saskia de Groot Erasmus University / Erasmus University / the Netherlands Carin Uyl-de Groot Erasmus University / Margreet Franken Erasmus University / Koopmanschap Erasmus University / /

IndustryTerm

health technology / pharmaceutical industry / genomics technologies / medical technology assessment / imaging / pharmaceutical reimbursement system / diagnostic tools / medical imaging services / health insurance projects / analytical software / gene technology fingerprints / health technology assessment / possible solutions / healthcare / regulatory systems / health insurance / drug reimbursement systems / healthcare services / treatment of colon cancer / genetic technologies / diagnostic and stratifying tools / genomics technology / diagnostic tool / /

MedicalCondition

multiple myeloma / ischemic stroke / rheumatoid arthritis / multiple sclerosis / blood cancer / cardiovascular diseases / breast cancer / respiratory diseases / leukemia / tumor / cancer / tumors / same illness / stroke / diabetes / conceptual disease / diseases / metabolic orphan disease / COPD / colorectal cancer / Conclusion Objective Acute myeloid leukemia / heterogeneous disease / colon cancer / severe COPD / hematologic diseases / multiple myeloma patient group / Pompe disease / autoimmune diseases / acute myocardial infarction / initial tumor / disease / acute leukemia / multiple myeloma side / full disease / cardiovascular disease / treatment Rheumatoid Arthritis / several other chronic diseases / inflammation / /

MedicalTreatment

Enzyme replacement therapy / /

Organization

UCLA / Los Angeles / the Netherlands Ken Redekop Erasmus University / Belgian Health Care Knowledge Centre / VU University Amsterdam / Dutch Ministry of Foreign Affairs / Koopmanschap Erasmus University / Roijen Erasmus University / Institute for Medical Technology Assessment / University of Oxford / the Netherlands Lucas Goossens Erasmus University / Hematology Ken Redekop Erasmus University / University of Maastricht / Center for Lysosomal and Metabolic Diseases Ans / Dutch Asthma Foundation / Health Care Insurance Board / Maastricht University / Medical Center / Center for Translational Molecular Medicine / the Netherlands Maureen Rutten-van Mölken Erasmus University / European International Society for Pharmacoeconomics / the Netherlands Bob Löwenberg Erasmus University Medical Center / Erasmus University Rotterdam / the Netherlands Authors Pepijn Vemer Erasmus University / University of British Columbia / Vancouver / the Netherlands Marloes Hagemans Erasmus University Medical Center / Organization for Health Research and Development / Presenters Tim Kanters Erasmus University / Congress / Institute for Medical / European International Society for Pharmacoeconomics and Outcomes Research / Center for Lysosomal / Emory University in Atlanta / the Netherlands Carin Uyl-de Groot Erasmus University / Presenters Annemieke Leunis Erasmus University / Outcomes Research / /

Person

Maureen Rutten / Maureen Rutten-van / Carin Uyl-de Groot / Jennifer Gaultney / Ken Redekop / Igna Bonfrer / Rian Rijnsburger / Hutton Framework / Annemieke Leunis / Tim Kanters / Leona Hakkaart / Maureen Rutten-van Mölken / /

Position

project leader / senior researcher / Professor / microsimulation Markov model / health scientist / junior researcher / minister / disease progression model for AML / researcher / associate professor of healt economics and vice-director / model / assistant professor / general practitioner and physiotherapist / /

ProvinceOrState

British Columbia / Georgia / /

PublishedMedium

Health Economics / /

Region

West Kenya / /

Technology

diagnostic tests / human genome / medical imaging / health technology / Bioinformatics / BioChips / genomics technology / AML genomics technologies / /

SocialTag